Structures by: González-González J. S.
Total: 13
Diethyl N,N'-[1,3-(2,4,6-trimethyl)phenylene]dioxamalate
C17H22N2O6
CrystEngComm (2011) 13, 14 4748
a=8.0020(3)Å b=15.7340(5)Å c=14.3370(6)Å
α=90° β=102.76(4)° γ=90°
Diethyl N,N'-[1,3-(2-methyl)phenylene]dioxamalate
C15H18N2O6
CrystEngComm (2011) 13, 14 4748
a=8.2302(12)Å b=23.218(3)Å c=8.1795(12)Å
α=90.00° β=94.665(2)° γ=90.00°
N,N-Bis[(2-(2-hydroxyethylamino)oxalyl)]-1,3- (5-tertbuthyl-2-methoxy)phenylenediamine
C19H28N4O7
CrystEngComm (2011) 13, 14 4748
a=13.066(3)Å b=24.384(5)Å c=13.303(3)Å
α=90° β=90.00(3)° γ=90°
N,N'-Bis(2-(2-hydroxyethylamino)oxalyl)-1,3-(2-methyl) phenylenediamine
C15H20N4O6
CrystEngComm (2011) 13, 14 4748
a=9.0080(18)Å b=9.5510(19)Å c=10.5930(19)Å
α=94.80(2)° β=99.01(3)° γ=109.34(3)°
N,N'-Bis-[2-(2-(2-hydroxyethoxy)ethylamino) oxalyl]-1,3-(2,4,6-trimethyl)phenylenediamine
C21H32N4O8
CrystEngComm (2011) 13, 14 4748
a=11.4567(6)Å b=12.9050(7)Å c=16.4558(10)Å
α=90.00° β=101.828(2)° γ=90.00°
Diethyl N,N'-(1,3-(5-tert-buthyl-2- methoxy)phenylene)dioxamalate
C19H26N2O7
CrystEngComm (2011) 13, 14 4748
a=9.9640(3)Å b=10.2180(3)Å c=10.5790(4)Å
α=80.969(2)° β=87.691(2)° γ=87.649(1)°
Diethyl N,N'-[1,3-(2,4,6-trimethyl)phenylene]dioxamalate
C17H22N2O6
CrystEngComm (2011) 13, 14 4748
a=8.0352(7)Å b=16.0173(14)Å c=14.3980(14)Å
α=90° β=102.681(2)° γ=90°
2,6-Diaminopyridine--piracetam (1/1)
C5H7N3,C6H10N2O2
Acta crystallographica. Section C, Structural chemistry (2017) 73, Pt 10 767-772
a=12.5854(10)Å b=10.0901(7)Å c=19.8568(16)Å
α=90° β=90° γ=90°
<i>N^2^</i>,<i>N^2'^</i>-bis[2-(morpholin-4-yl)propyl]- <i>N^1^</i>,<i>N</i>^1'^-(1,2-phenylene)dioxalamide dimethyl sulfoxide monosolvate
C24H36N6O6,C2H6OS
Acta crystallographica. Section C, Crystal structure communications (2013) 69, Pt 1 66-69
a=8.6704(8)Å b=11.0052(10)Å c=16.3277(15)Å
α=107.425(2)° β=98.036(2)° γ=91.517(2)°
5-Methyl-1,3-benzenediol-diethyl N,N'-(1,3-phenylene) dioxalamate complex
C21H24N2O8
Crystal Growth & Design (2014) 14, 2 628
a=4.9410(2)Å b=18.7803(5)Å c=11.2062(4)Å
α=90.00° β=97.223(3)° γ=90.00°
1,3-Benzenediol-diethyl N,N'-(1,3-phenylene)dioxalamate complex
C74H82N8O30
Crystal Growth & Design (2014) 14, 2 628
a=15.1465(4)Å b=17.4664(6)Å c=17.4943(5)Å
α=113.765(3)° β=108.654(2)° γ=98.054(2)°
4,6-di-tbutyl-1,3-benzenediol-diethyl N,N'-(1,3-phenylene)dioxalamate
C29H39Cl3N2O8
Crystal Growth & Design (2014) 14, 2 628
a=15.8182(7)Å b=18.9181(6)Å c=11.3683(4)Å
α=90.00° β=92.369(4)° γ=90.00°
2,6-Diaminopyridine--theophylline (1/1)
C5H7N3,C7H8N4O2
Acta crystallographica. Section C, Structural chemistry (2017) 73, Pt 10 767-772
a=9.5439(3)Å b=15.6588(5)Å c=9.4887(3)Å
α=90° β=109.9270(10)° γ=90°